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This study investigated long-term outcome of catheter ablation of right anteroseptal atrio-
ventricular (AV) accessory pathways (AP) located close to the His bundle.
Methods: Between April 2003 and June 2011, 26 patients (6 females, age 35713 years)
underwent catheter ablation of right anteroseptal AP. These APs represented 10% of all 248
APs ablated within the given reference period. Elimination of AP conduction in both
directions and preservation of normal AV conduction were the ablation procedure endpoints.
Results: First ablation was effective in 18 (69%) patients. After repeat ablation, AP was
permanently eliminated in 22 (85%) patients (one, two, and three ablation procedures in 16, 5,
and 1 patient, respectively). Ablation failed in 4 patients (1 procedure in 3 patients, 2
procedures in 1 patient). During 56727 (4–102) month follow-up period since the last
ablation, no late AP conduction recovery was found, and no late advanced AV block occurred.
Post-ablation AV node Wenckebach point was present at the pacing rate of 176726 (130–230)
beats per minute. Of the two engaged operators, more experienced operator successfully
accomplished first, second, and third ablation procedure in 14/16 (88%), 5/5 (100%), and 1/1
(100%) patients, respectively, the latter operator attained successful ablation in 4/10 (40%)
and 1/2 (50%) patients at the first and second ablation procedures, respectively.
Conclusion: Ablation of right anteroseptal AP close to the His bundle is feasible and safe. Late
advanced AV block was not observed. Individual operator’s experience influenced ablation
efficacy.
& 2012 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z.o.o. All
rights reserved.1. Introduction
Catheter ablation of atrio-ventricular (AV) accessory path-
ways (APs) has proved to be highly successful and safe
curative method [1,2]. AP location in vicinity of the AV
node and His bundle increases the risks of AV conduction
block, sets the operator higher demands to make adequate
decisions, and decreases ablation efficacy [3–7]. On account
of general decrement in the number of patients undergoingch Society of Cardiology.
51; fax: þ420 558304457.
. Fiala)AP ablation, and relatively rare occurrence of APs located
close to the AV conduction system, there is a conside-
rable shrinkage of opportunity for younger electrophysiolo-
gists to encounter and successfully/safely manage complex
AP forms.
This study included patients with right anteroseptal APs
localized in vicinity of His bundle. Immediate and long-term
efficacy and safety of AP ablation carried out in one center
within a period of eight years were evaluated.Published by Elsevier Urban & Partner Sp.z.o.o. All rights reserved.
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2.1. Study population
Between April 2003 and June 2011, 26 patients (6 females), aged
35713 (19–59) years, underwent catheter ablation of a right
anteroseptal AP located close to the His bundle. These APs
represented 10% of all 248 APs in 247 patients who underwent AP
ablation within the given reference period. Ablation was
indicated for recurrent symptomatic orthodromic AV reentry
tachycardia (oAVRT), seven (27%) patients had history of syncope,
which was connected with head injury and subdural hematoma
in one case. One patient was resuscitated for ventricular fibrilla-
tion prior to his last ablation procedure. Eight (31%) patients
previously underwent one to three unsuccessful AP ablation
procedures elsewhere (details in Table 1). Only patients, who
were given at least one ablation energy delivery, were included
into the analysis. Four patients, who, following the diagnostic
part of the study, were decided not to be ablated, were excluded.
Two patients with right midseptal AP, i.e. AP located beneath the
His bundle close to the compact AV node, were also excluded.2.2. Definitions
Tricuspid annulus is basically triangular in shape tapering
towards its upper-anterior part, at the septal aspect of whichTable 1 – Baseline characteristics.
N. M/F Age
(yrs)
Symptom
history (months)
No.
AAD
Syncope
1 M 55 9 2 þ
2 F 21 4 1 þ
3 M 19 15 1
4 M 50 30 4 þ
5 M 32 16 1
6 M 27 14 1
7 M 48 8 2
8 M 35 15 2
9 M 41 20 1 þ
10 M 40 23 4 þ
11 M 59 31 3
12 F 19 9 2
13 M 38 10 2
14 F 55 20 2
15 Zˇ 28 15 1 þ
16 M 32 8 1 þ
17 F 22 15 0
18 F 51 10 2 þ
19 M 36 17 0
20 M 46 12 1
21 M 24 6 2
22 M 20 2 2
23 F 27 5 1
24 M 43 18 0 þ
25 M 25 13 1
26 M 23 16 0
AAD ¼ antiarrhythmic drugs; CPR ¼ cardio-pulmonary resuscitation for v
procedures ¼ number of ablation procedures performed in referring centhe His bundle is located. This study included patients with AP
localized at the anterior (superior) septal segment of the tricuspid
annulus within 10 mm from the His bundle, i.e. in the segment
bounded by the apex of the tricuspid annulus superiorly and His
bundle inferiorly (Fig. 1). According to the standard nomencla-
ture, these APs are usually classified as anteroseptal. APs, after
ablation of which a distinct high-frequency His bundle potential
was recorded, were designated para-hisian APs (Fig. 2), never-
theless at least a tiny far-field His bundle potential was recorded
at the site of successful ablation in all included patients
corroborating proximity of both the AP and the His bundle.2.3. Electrophysiological study
For the electrophysiological study, diagnostic catheters were
deployed in the right ventricle (4-pole catheter, Biosense-
Webster, Diamond Bar, CA, USA) and coronary sinus (10-pole
catheter (Daig, St. Jude, Minnetonka, MN, USA)), and a
mapping/ablation catheter was introduced. In addition, a
4-pole diagnostic catheter could be placed for continuous His
bundle recording. Surface electrocardiograms and bipolar
endocardial electrograms were filtered at a band-pass setting
of 30–500 Hz and recorded digitally (Cardiolab System,
Prucka Engineering, Sugar Land, TX, USA), and maximum
amplification gain 10,000 for mapping signal was used on the
mapping/ablation catheter. During the diagnostic part of theCPR No. prior
ablations elsewhere
No. ablation
procedures
Follow-up
(months)
0 1 102
1 1 99
0 2 86
1 2 86
1 1 86
0 2 84
0 1 83
1 1 81
0 1 78
þ 2 2 62
1 1 67
1 1 61
0 3 45
0 2 46
3 1 47
0 1 47
0 1 47
0 2 39
0 1 44
0 1 42
0 1 30
0 1 28
0 1 22
0 1 22
0 1 18
0 1 4
entricular fibrillation; F ¼ female; M ¼ male; yrs ¼ years; N. ablation
ter.
Fig. 2 – An example of successful manifest para-hisian accessory pathway ablation. During sinus rhythm before ablation,
12-lead surface ECG shows preexcited QRS complex, and the distal electrode bipole of the ablation catheter (ABL d) records
simultaneously local His bundle potential (H) and accessory pathway potential (AP). Following ablation and AP conduction
elimination, preexcitation disappeared and a typical His bundle recording of non-preexcited sinus beat was revealed
exhibiting distinct high-frequency His bundle potential. RVa d ¼ intracardiac bipolar recording from the right ventricular apex.
Fig. 1 – Diagram showing location of right-sided anteroseptal accessory pathways in vicinity of the His bundle. True para-
hisian pathways represent a subset of pathway located immediately next to the His bundle. Approximately left anterior
oblique view of the valve annuli.
C O R E T VA S A 54 ( 2012 ) e8 –e15e10procedure, retrograde and antegrade (in manifest APs) conduc-
tion capacity, i.e. pacing rate at which the VA or AV activation
remained in 1:1 relation, were determined, and oAVRT wasinduced. After ablation, Wenckebach point of the AV node, and
AH and HV intervals were measured (they could be also assessed
before ablation in patients with concealed AP), and retrograde
Fig. 3 – A flow-chart showing immediate technical ablation results and subsequent clinical outcome.
C O R E T VA S A 54 ( 2012 ) e8 –e15 e11conduction capacity of the AV node (VA dissociation or the so-
called retrograde Wenckebach point of the AV node) were further
ascertained.
2.4. Catheter ablation
Ablation catheter was primarily introduced from the femoral
vein via inferior vena cava and may have required stabiliza-
tion on the tricuspid annulus by a long sheath. In some cases
of inadequate catheter stability at the ablation site, the
catheter was secondarily introduced from the subclavian or
jugular access for ‘‘hooking’’ and stabilizing the catheter at
the apex of the tricuspid annulus from above via superior
vena cava. Temperature-controlled ablation delivered
through the catheter with a standard 4 mm tip (22 proce-
dures) or occasionally cryoablation (3 procedures) were
employed mainly during the first years, while power-con-
trolled ablation via catheter with irrigated 3.5 mm tip
electrode (10 procedures) was largely used in the later years
(Table 2). Radiofrequency energy was applied with a Stockert
generator (Biosense Webster). Irrigation of 17 ml/min (0.9%
saline) through a Cool Flow pump (Biosense-Webster), and
temperature and power limits of 42 1C and 30 W, respectively,
were used. Cryoablation at 70 1C was applied as a 6 min-
lasting individual delivery through the catheter Freezor
(Cryocath Technologies Inc., Montreal, Quebec, Canada).
The site of ablation was determined by standard mapping
criteria. The earliest local atrial activation during retrograde
VA conduction was searched during ventricular pacing or
ongoing oAVRT. If then ablation energy delivery was not
feasible in sinus rhythm, it was preferentially applied during
ongoing oAVRT and not ventricular pacing to avoid masking
of impending conduction block over the AV node/His bundle.
The earliest local ventricular activation in relation to theonset of delta wave of the QRS complex on the surface ECG
(V-delta) was determined during sinus rhythm or atrial
pacing. Ablation was preferentially performed during sinus
rhythm to monitor AV conduction and detect possible
junctional rhythm. Similarly, in concealed APs, once the AP
was localized by successful ablation energy delivery during
oAVRT, ablation was finished by subsequent energy delivery
during sinus rhythm.
After the diagnostic part of the procedure, the operator
discussed and explained to the patient all risks inherent to
the ablation in given location and ablation was performed
only with the patient’s consent. During subsequent procedure
course, if the AP location appeared too risky to the operator,
ablation could be electively prematurely terminated.
Elimination of the AP conduction in both directions was the
procedure endpoint, and the result was checked and tested by
ventricular and atrial pacing for at least 30 min. Then, after
determining AV node and His bundle conduction character-
istics, the procedure was terminated.2.5. Follow-up
Patients were seen in the outpatient department within the
first 3 months after ablation and then were contacted over
telephone or were repeatedly seen on the out-patient basis
when needed. They were screened for palpitations and other
arrhythmic symptoms and for prospective delayed AV con-
duction disturbance and pacemaker implantation.2.6. Statistical analysis
Data were expressed as mean7standard deviation or
proportions.
Table 2 – Ablation procedure characteristics and results.
No. AP
location
Manif /Conc Antegrade
AP Cond (bpm)
Retrograde
AP Cond (bpm)
AP Elim  AP Elim þ SVC
access
Abl.
energy
WP rWP Op
1 AS Manif 240 250 1 RF 160 Dis A
2 AS Conc Na 280 1 1 RF 150 120 A
3 AS Manif 200 230 1 RF 210 170 A
Conc NA 220 1 RF 220 170 A
4 P-H Manif 260 270 1 el RF NA NA A
Manif 250 240 1 Cryo, RF 180 180 A
5 AS Manif 160 190 1 Cryo 180 180 A
6 P-H Manif 210 190 1 RF 160 Dis A
210 190 1 Cryo 180 Dis A
7 AS Conc NA 250 1 RF 230 150 A
8 AS Conc Na 240 1 RF 180 Dis A
9 P-H Conc Na 220 1 RF 170 120 A
10 P-H Manif 210 220 1 RF NA NA A
Manif 200 200 1 RF cool 130 130 A
11 AS Manif 180 200 1 RF 170 Dis A
12 P-H Manif 190 210 1 1 RF 180 Dis A
13 P-H Manif 180 190 1 el RF NA NA B
Manif Rudim 180 1 RF cool 190 Dis A
Manif Rudim 180 1 RF cool 180 Dis A
14 P-H Manif 250 250 1 RF NA NA B
Manif 230 250 1 RF 140 Dis B
15 AS Manif 220 220 1 RF cool 190 160 A
16 AS Manif 250 250 1 1 RF 180 220 B
17 AS Manif 250 250 1 RF 200 200 B
18 P-H Manif 210 200 1 el RF NA NA B
Manif 230 200 1 el RF NA NA B
19 AS Manif 180 200 1 1 RF cool 200 210 A
20 P-H Conc NA 200 1 el RF cool NA NA B
21 P-H Manif 250 220 1 RF cool 230 230 B
22 P-H Manif 120 160 1 el RF 140 NA B
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3.1. AP Characteristics
AP locations are shown in Table 2. Eighteen (69%) patients had
a manifest AP and 8 (31%) patients exhibited a concealed AP.
First ablation that was followed by AP conduction recovery
significantly changed AP conduction parameters in 2 patients.
In both instances, original antegrade manifest AP conduction
with a relatively high conduction capacity either entirely
disappeared (n ¼ 1) or remained rudimental (n ¼ 1), while the
retrograde conduction did not significantly change.
Prior to the first ablation, in patients with manifest AP,
antegrade AP conduction allowing 1:1 AV activation during
atrial pacing was present up to the pacing rate of 207742
(120–260)/min (n ¼ 18), while retrograde AP conduction with
1:1 VA activation during ventricular pacing was present up to
the pacing rate of 218731 (160–280)/min (n ¼ 26).
3.2. Repeat ablation and outcome
One and two repeat ablations were performed in 7 and 1
patients, respectively. In total, 34 ablation procedures were
performed. First ablation was technically successful in 18
(69%) patients. AP conduction recovered with dealy in 2 of
these patients. In both instances, the AP conduction recur-
rence was successfully treated by repeat ablation.
First ablation failed to eliminate AP conduction in 8 (31%)
patients. In 2 patients, AP ablation failed despite all standard
efforts to accomplish the procedure; repeat ablation was
successful in both these patients. In another 6 patients,
ablation procedure was electively prematurely terminated
after consultation with the patient. Two of these patients
subsequently underwent a successful repeat ablation, with
further AP conduction recurrence in 1 patient that was
eventually successfully managed by a second repeat ablation.
One patient underwent unsuccessful repeat ablation that was
again prematurely terminated for safety reasons. Three
patients were not offered further ablation.
In total, AP conduction was permanently eliminated in 22
(85%) patients (in 16 patients by 1 procedure, in 5 patients
after 2 procedures, and in 1 patient after 3 procedures). In
contrast, the procedure was electively prematurely termi-
nated in 4 patients (1 procedure in 3 patients, 2 procedures in
1 patient) (Table 2) (Fig. 3). All 4 (33%) failed ablation
procedures were present in patients with true para-hisian
APs (n ¼ 12) (Table 2).
3.3. Procedure, fluoroscopy and ablation energy
application time
Mean procedure, fluoroscopy, and radiofrequency energy
delivery times were 139771 (60–270), 14710 (2–41), and
12710 (1–34) minutes. In addition, cryoablation was employed
in 3 patients. Cryoablation by freezing at 70 1C was success-
ful in 2 patients (one and three applications, respectively),
while cryoablation with 13 applications at 70 1C failed to
eliminate AP in another patient; nevertheless, this procedure
was eventually successfully completed with radiofrequency
C O R E T VA S A 54 ( 2012 ) e8 –e15e14ablation. Catheter had to be stabilized by long sheath in 2
instances, and ablation was successfully finished by introdu-
cing catheter via the subclavian or jugular approach in
another 4 cases (Table 2).3.4. Ablation energy
Temperature-controlled radiofrequency ablation was suc-
cessfully used in 12 patients at the first ablation procedure,
and in 3 patients at the second procedure. It failed in 6 cases
of the first procedure and 1 case of the second procedure.
Power-controlled cooled radiofrequency ablation was suc-
cessfully employed in 5 instances of the first procedure, 2
instances of the second procedure, and 1 third ablation
procedure. It failed in two instances of the second procedure.
Cryoablation was successfully used in 1 case of the first
ablation procedure and 1 s ablation procedure. It failed in 1
case of the second ablation that was successfully completed
by temperature-controlled radiofrequency current (see
above).
In summary, temperature-controlled radiofrequency abla-
tion was used successfully in 15 (68%) cases and unsuccess-
fully in 7 (32%) cases, power-controlled radiofrequency
ablation was used successfully in 8 (80%) cases and unsuc-
cessfully in 2 (20%) cases, and cryoablation succeeded in 2
(67%) cases and failed in 1 (33%) case.3.5. AV nodal and His bundle conduction characteristics
after ablation
Retrograde conduction over the AV node could not be
assessed due to ineffective ablation in 4 patients. Antegrade
AV nodal conduction was not ascertained in 1 patient with
ineffective ablation and AP conduction capacity exceeding AV
nodal conduction. In the remaining patients with successful
ablation, AV nodal Wenckebach point after the last ablation
was present at the pacing rate of 176726 (130–230) bpm. No
patient developed grade I–III AV block. When assessing
retrograde AV nodal conduction, 9 patients displayed com-
plete VA dissociation, and another 13 patients exhibited
retrograde Wenckebach point of the AV node at the pacing
rate 168739 (120–230) bpm (Table 2). AH and HV intervals
were in normal range in all patients. Pacemaker was later
implanted in one patient for intermittent pauses due to sino-
atrial node dysfunction.3.6. Long-term outcome
All patients (n ¼ 22/85%) with successful AP ablation re-
mained without AP conduction recurrence for 56727 (4–102)
months since the last ablation. No delayed higher degree AV
block requiring pacemaker implantation occurred. Patient #10
with implanted pacemaker for sinus pauses underwent later
another electrophysiological study for isolated syncope con-
nected with documented atrial fibrillation. AP conduction
recurrence was excluded and normal AV nodal and His
bundle conduction parameters were proved, specifically AV
nodal Wenckebach point was present at 160 bpm.3.7. Operator’s experience and results
Of the four operators performing AP ablation within the
reference period, two operators (denominated A, B) were
directly engaged in ablation of anteroseptal AP close to the
His bundle (Table 2). Operator A carried out all ablation
procedures in 16 patients, and two repeat ablations in 1
patient whose first ablation was performed by the operator B.
Operator’s A immediate success rate of the first ablation
procedure was 14/16 (88%), of the second procedure 5/5
(100%), and of the third procedure 1/1 (100%). Operator’s B
immediate success rate of the first procedure was 4/10 (40%)
and of the second procedure 1/2 (50%). In total, operator A
eventually succeeded in all 18 patients in whose ablation he
was engaged. Operator B eventually successfully ablated 5
patients, while electively terminated the procedure in an-
other 5 patients (two times in 1 patient).4. Discussion
The results of this retrospective analysis of patients under-
going catheter ablation for right anteroseptal AP located close
to the His bundle are as follows: (1) Catheter ablation is
feasible and safe in most of the patients and ablation failure
usually results from elective decision to terminate the
procedure prematurely. (2) Outcome was not affected by the
type of used ablation energy, cooled power-controlled radio-
frequency ablation was utilized safely in all cases. (3) Ablation
success was influenced by the operator’s experience. (4) In
long-term, no late AP conduction recurred and no late higher-
degree AV block developed.
In the modern era, catheter ablation of APs exceeds 90%
success rate even after the first ablation procedure, and
improves nearly to 100% after repeat ablation with minimal
risk of complications 100% [1,2]. Yet, APs located in the
vicinity of AV node/His bundle place patients and operators
before difficult decisions and technical challenges. Earlier
pioneering studies have demonstrated ablation of anterosep-
tal (above His bundle) or midseptal (beneath His bundle) APs
largely feasible, although the risk of higher-degree AV block
cannot be excluded [3–7]. These APs are fortunately relatively
rare, and likewise in our study, have been previously shown in
approximately 10% of the patients undergoing AP ablation
[2,5,8]. Relative safety of ablation of APs confined to the
segment of the tricuspid annulus above the His bundle may
lie in their common superficial endocardial position, while
the His bundle gets buried into the membranous ventricular
septum enveloped and protected against injury by the fibrous
casing. Therefore, the ablation effect on the AP can be partly
dissociated from the His bundle despite proximity of both the
structures.
Little is known on the late effect of ablation near AV
conduction system. Delayed AV conduction block after septal
ablation is possible [9]. In the subacute phase, it can be caused
by extension of the coagulation due to the marginal micro-
vasculature damage. However, very late negative impact of
uncomplicated ablation in the para-hisian location can be
also speculated. Late AV block resulting largely from sponta-
neous degenerative changes particularly in older patients can
C O R E T VA S A 54 ( 2012 ) e8 –e15 e15be facilitated by previous permanent ablation-induced de-
struction of some inputs into the AV node. In our study,
however, no late higher-degree AV block occurred (and at the
same time, no delayed AP conduction recovery was observed)
during the 56727 month follow-up, although 12 patients
underwent ablation more than 5 years ago, and 9 of them
underwent Z2 ablation procedures in our center or else-
where. In addition, at the time of ablation, 5 patients were
Z50 years and another 5 patients Z40 years old.
Right anteroseptal AP ablation efficacy is high despite
unfavorable location and can exceed 90% [7]. In our study,
first ablation procedure failed in 8 (31%) patients, never-
theless, the result was mainly influenced by guarded
approach leading to relatively frequent premature procedure
termination. If the ablation had not been commenced at all in
6 patients, in whom the procedure was electively terminated,
the first ablation efficacy would have changed to 18/20 (90%).
We repeated ablation in 7 (27%) patients (prior ablation
procedures completed in other centers were not calculated).
In total, ablation was successful in 22 (85%) patients. Repeat
ablation was not indicated in 3 patients, and again prema-
turely terminated in 1 patient. Although two most experi-
enced operators were engaged, long prior experience with the
ablation method proved to importantly influence final result.
Risky AP location incited use of alternative ablation
energies and mapping techniques, first off all cryoablation
[10,11], or electromagnetic navigation [12,13] that might in
theory reduce the risk of AV conduction damage by specific
nature of the myocardial lesion formation, or by decreasing
the risk of catheter dislocation during energy delivery. In our
study, the energy used (temperature-controlled or cooled
power-controlled radiofrequency or cryoablation) did not
affect ablation success rate; however, cryoablation was
employed in only 3 cases. On the other hand, cooled power-
controlled radiofrequency ablation, which produces larger
lesion and might be regarded more aggressive, was routinely
used in the later stages of the referring period to improve AP
ablation efficacy in general, and proved to be safe without
inadvertent AV conduction damage also in the right ante-
roseptal region.5. Conclusion
Catheter ablation of right anteroseptal AP located close to the
His bundle can be accomplished highly effectively and safely
without complicating AV conduction block. Ablation efficacy
was not essentially dependent neither on the ablation energy
nor modification of its delivery. Successful ablation was
significantly influenced by individual operator’s experience.R E F E R E N C E S
[1] N. Dagres, J.R. Clague, H. Kottkamp, et al., Radiofrequency
catheter ablation of accessory pathways: Outcome and use of
antiarrhythmic drugs during follow-up, European Heart
Journal 20 (1999) 1826–1832.
[2] R. Kobza, H. Kottakmp, C. Piorkowski, et al., Radiofrequency
ablation of accessory pathways: contemporary success rate
and complications in 323 patients, Zeitschrift fur Kardiologie
94 (2005) 193–199.
[3] K.H. Kuck, M. Schlu¨tter, S. Gu¨rsoy, Preservation of atrioven-
tricular nodal conduction during radiofrequency current
catheter ablation of midseptal accessory pathways, Circula-
tion 86 (1992) 1743–1752.
[4] M. Schlu¨tter, K.H. Kuck, Catheter ablation from right atrium
of anteroseptal accessory pathways using radiofrequency
current, Journal of the American College of Cardiology 19
(2002) 663–670.
[5] J.F. Warin, M. Hassaguerre, C. D’Ivernois, et al., Catheter
ablation of accessory pathways: techniques and results in
248 patients, Pacing and Clinical Elecrophysiology 13 (1990)
1609–1614.
[6] C.T. Tai, S.A. Chen, C.E. Chang, et al., Electrocardiographic
and electrophysiologic characteristics of anteroseptal, mid-
spetal, and para-Hisian accessory pathways: implication for
radiofrequency catheter ablation, Chest 109 (1996) 730–740.
[7] J. Brugada, M. Puigfel, L. Mont, et al., Radiofrequency ablation
of anteroseptal, para-Hisian, and midseptal accessory path-
ways using a simplified femoral approach, Pacing and
Clinical Elecrophysiology 21 (1998) 735–741.
[8] W.M. Jackman, X.Z. Wang, K.J. Friday, et al., Catheter ablation
of accessory atrioventricular pathways (Wolf–Parkonson–-
White syndrome) by radiofrequency current, N England
Journal of Medicine 324 (1991) 1605–1611.
[9] G. Pelargonio, R.I. Fogel, T.K. Knilans, et al., Late occurence of
heart block after radiofrequency catheter ablation of the
septal region: clinical follow-up and outcome, Journal of
Cardiovascular Electrophysiology 12 (2001) 56–60.
[10] F. Gaita, M. Hassaguerre, C. Giustetto, et al., Safety and
efficacy of cryoablation of accessory pathways adjacent to
the normal conduction system, Journal of Cardiovascular
Electrophysiology 14 (2003) 825–829.
[11] Y. Bar-Cohen, F. Cecchin, M.E. Alexander, et al., Cryoablation
for accessory pathways located near normal conduction
tissues or within the coronary venous system in children and
young adults, Heart Rhythm 3 (2006) 253–258.
[12] S. Ernst, H. Hachiya, J.K. Chun, et al., Remote catheter
ablation of parahisian accessory pathways using a novel
magnetic navigation system—a report of two cases, Journal
of Cardiovascular Electrophysiology 16 (2005) 659–662.
[13] D.R. Davis, A.S. Tang, D.H. Birnie, et al., Successful ablation of
concealed accessory pathway using a remote magnetic
navigation system following failure by conventional meth-
ods, Journal of Interventional Cardiac Electrophysiology 16
(2006) 149–151.
